NanoViricides
NNVC
#10068
Rank
C$33.18 M
Marketcap
C$1.54
Share price
-0.88%
Change (1 day)
-14.02%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: C$33.18 Million

As of March 2026 NanoViricides has a market cap of C$33.18 Million. This makes NanoViricides the world's 10068th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026C$33.18 M-5.58%
2025C$35.14 M13.82%
2024C$30.88 M94.33%
2023C$15.89 M-9.13%
2022C$17.48 M-68%
2021C$54.63 M40%
2020C$39.02 M207.58%
2019C$12.68 M-32.99%
2018C$18.93 M-72.98%
2017C$70.08 M-16.26%
2016C$83.69 M-11.58%
2015C$94.64 M-46.99%
2014C$0.17 B-30.17%
2013C$0.25 B243.65%
2012C$74.4 M-19.71%
2011C$92.66 M-54.56%
2010C$0.20 B72.87%
2009C$0.11 B-2.38%
2008C$0.12 B160.69%
2007C$46.35 M

End of Day market cap according to different sources

On Mar 18th, 2026 the market cap of NanoViricides was reported to be:

C$33.18 Million
by Nasdaq info icon info icon
C$33.18 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
C$240.68 B 725,102.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$388.45 B 1,170,346.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$165.90 B 499,790.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$143.23 B 431,480.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
C$2.23 B 6,643.41%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$3.15 B 9,398.45%๐Ÿ‡บ๐Ÿ‡ธ USA